Effectiveness of influenza vaccine against influenza A in Europe in seasons of different A(H1N1)pdm09 and the same A(H3N2) vaccine components (2016–17 and 2017

Effectiveness of influenza vaccine against influenza A in Europe in seasons of different A(H1N1)pdm09 and the same A(H3N2) vaccine components (2016–17 and 2017–18)

Published:2019-12 Issue: Volume:3 Page:100042
ISSN:2590-1362
Container-title:Vaccine: X
language:en
Short-container-title:Vaccine: X

Author:

Kissling Esther^ORCID,Pozo Francisco,Buda Silke,Vilcu Ana-Maria,Rizzo Caterina,Gherasim Alin,Horváth Judit Krisztina,Brytting Mia,Domegan Lisa,Meijer Adam,Paradowska-Stankiewicz Iwona,Machado Ausenda^ORCID,Vučina Vesna Višekruna,Lazar Mihaela,Johansen Kari,Dürrwald Ralf,van der Werf Sylvie,Bella Antonino,Larrauri Amparo,Ferenczi Annamária,Zakikhany Katherina,O'Donnell Joan,Dijkstra Frederika,Bogusz Joanna,Guiomar Raquel,Filipović Sanja Kurečić,Pitigoi Daniela,Penttinen Pasi,Valenciano Marta^ORCID

Funder

European Union's Horizon 2020 research and innovation programme

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference38 articles.

1. ECDC, ‘Influenza virus characterisation - Summary Europe, June 2016’, Jul. 2016.

2. C. Adlhoch, R. Snacken, A. Melidou, S. Ionescu, P. Penttinen, and The European Influenza Surveillance Network, ‘Dominant influenza A(H3N2) and B/Yamagata virus circulation in EU/EEA, 2016/17 and 2017/18 seasons, respectively’, Euro Surveill. Bull. Eur. Sur Mal. Transm. Eur. Commun. Dis. Bull., vol. 23, no. 13, 2018.

3. Excess all-cause and influenza-attributable mortality in Europe, December 2016 to February 2017;Vestergaard;Euro. Surveill. Bull. Eur. Sur Mal. Transm. Eur. Commun. Dis. Bull.,2017

4. EuroMOMO, ‘European monitoring of excess mortality for public health action - EuroMOMO’. [Online]. Available: [Accessed: 14-Aug-2018]. http://www.euromomo.eu/index.html.

5. I-MOVE: a European network to measure the effectiveness of influenza vaccines;Valenciano;Euro Surveill. Bull. Eur. Sur Mal. Transm. Eur. Commun. Dis. Bull.,2012

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Seasonal influenza vaccine performance and the potential benefits of mRNA vaccines;Human Vaccines & Immunotherapeutics;2024-04-15

2. Influenza vaccination in pregnant women in Iceland 2010–2020 and the burden of influenza in pregnant women and their infants;Vaccine;2024-03

3. Dynamic analysis and optimal control of influenza model with discrete age structure;Mathematical Methods in the Applied Sciences;2024-01-11

4. Influenza vaccine effectiveness in Europe: Results from the 2022–2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study;Influenza and Other Respiratory Viruses;2024-01

5. Seasonal Influenza Vaccine Effectiveness in Persons Aged 15–64 Years: A Systematic Review and Meta-Analysis;Vaccines;2023-08-04